01Map the compartments and their biological roles

Huh and colleagues’ original lung-chip study reconstructed an alveolar-capillary interface and incorporated breathing-associated mechanical deformation. The example shows how a device can represent a particular organ interface without being an entire functioning organ.Huh and colleagues — Reconstituting Organ-Level Lung Functions on a Chip (opens in a new tab)

Read the diagram for the actual cell populations and how the compartments communicate. A channel labelled vascular should lead to a description of the cells, fluid and barrier used to represent that environment.

Ask which part of the peptide question benefits from this arrangement. It may concern a barrier, an interaction between cell layers or a response under a defined physical condition.

A model that answers one of those questions can be valuable even if it lacks other organ functions. The interpretation becomes weaker when an interface-specific finding is silently expanded to the whole organism.

Keep the cell source and biological replication visible too. An engineered device does not replace the need to understand which cells it contains.

02Distinguish the applied setting from the measured state

A flow or mechanical setting describes what the apparatus was instructed to do. Read what evidence establishes the relevant physical and biological conditions during the experiment.

For an original reasoning example, two chips may use the same nominal pump setting while differing in channel dimensions. That shared setting alone does not establish an identical environment at the cells.

Do not substitute a device specification for evidence of barrier performance or cellular function. If the conclusion relies on an intact interface, find the measurement that assesses that property.

These distinctions are questions for reading the method, not instructions for building or operating a device. The appropriate validation depends on the claimed result.

03Follow the test material through the system

Grant and colleagues’ original PDMS-chip study combined measurements and modelling to examine drug concentration profiles affected by material interactions. It studied particular small-molecule behaviour; it does not establish a universal loss percentage for peptides.Grant and colleagues — Simulating drug concentrations in PDMS microfluidic organ chips (opens in a new tab)

For a peptide experiment, read whether exposure is described only at the inlet or also assessed elsewhere. An added concentration and the concentration experienced by a cellular compartment need not be treated as the same established quantity.

A fictional mass-accounting example starts with 100 units entering a setup and 70 recovered at its outlet during the stated collection window. The missing 30 units cannot automatically be assigned to cellular uptake.

The interpretation needs to consider what was measured about retained material, other compartments and the time window. The example deliberately leaves the cause unresolved; it is not a measured peptide-recovery result.

04Match the output to the intended use

An electrical, imaging, molecular or outflow measurement can each describe a different feature of the chip. Identify the endpoint and its comparison before deciding what the model demonstrated.

If a paper claims the system predicts a tissue response, look for the reference observations used to evaluate that prediction. A plausible design is a rationale; successful comparison provides additional evidence.

Retain variation between independently prepared devices and cell sources. Repeated samples from one channel do not automatically constitute independent models.

A clear summary names the biological interface, physical conditions, exposure evidence and supported endpoint. It then describes the demonstrated use of the platform, avoiding a blanket claim that one chip reproduces all organ behaviour or predicts every compound response.